Twist Bioscience stock surges 7.38% as Twist Bioscience promotes MRD Express custom target solution

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience surges 7.38% today

Highlights

TWST maintains a strong bullish trend, trading well above its medium- and long-term moving averages with solid trend momentum.
Short-term consolidation is evident as mixed momentum indicators contrast with ongoing net buying and near-term resistance at $94.
Forecast range for the coming week is $86–$102, with baseline expectation of sideways movement unless key support or resistance breaks.

The company describes MRD Express as rapid, scalable, and high-performance. Details are available through the provided links.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish trend holds as price tests resistance at moving averages

TWST is trading at $93.90, just above the MA-20 ($93.67), well above the MA-50 ($76.85) and MA-200 ($49.90), signaling a firm bullish trend in both mid- and long-term outlooks, while flattened short-term momentum may be emerging. The Ichimoku Kijun on D1 stands at $86.93, which acts as immediate support beneath the current price. Near-term support levels are clustered at the Ichimoku Kijun ($86.93) and the MA-50 ($76.85), while short-term resistance is at the MA-20 ($93.67) and the next key resistance aligns with the 52-week high near $105.41.

Divergence in momentum signals as buyers drive volatility and consolidation

Momentum signals are mixed: MACD indicates a strong buy and ADX on D1 signals ongoing trend strength, while RSI and CCI both print near-neutral, slightly bearish forecasts. Stoch RSI on D1 is flagged as oversold, yet BBP registers at 4.98, suggesting buyers are currently dominant and keeping the pressure upward, creating divergence between momentum and oscillators. In today’s session, TWST has surged 7.38% ($6.45), reflecting strong buying activity. Over the last week, TWST is up just $0.05 (a marginal 0.06%), trading near the upper part of its weekly range with volatility at 12.24%, signaling a consolidation phase after a sharp recovery from the weekly low.

Upside favored while consolidation persists within defined price range

For the coming week, a normalized forecast range anchors TWST between $86.00 and $102.00, keeping it within 20% of the current price and reflecting recent volatility. This range remains well above the 52-week low ($23.30) but below the 52-week high ($105.41), implying an elevated yet not overextended positioning. Based on three of four major weekly indicators signaling “Buy” or “Strong Buy” (RSI W1, ADX W1, MACD W1, and MA-50 W1), there is a high probability (75%) of upward movement, making a further decline less likely. The baseline scenario is sideways action within this corridor as consolidation continues. A bullish scenario could be triggered by a break above $94 (MA-20 and current resistance), targeting the upper boundary of the forecast range. Conversely, a bearish move would require a decisive drop below $86.93 (Kijun and support cluster), opening room for pullbacks toward $76.85 if selling pressure accelerates.

Previously it was reported that Twist Bioscience was exhibiting a strong bullish trend, supported by consistent upside momentum. In light of current developments, investors should monitor for potential shifts in direction, with sustained price consolidation or a decisive move likely to determine the prevailing trend in the near term.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.